Skip to product information
1 of 1

BT Lab

SKU:E4064hu

Human bladder cancer-associated nuclear matrix protein 4,BLCA-4 ELISA Kit

Human bladder cancer-associated nuclear matrix protein 4,BLCA-4 ELISA Kit

Regular price $458.00 USD
Regular price Sale price $458.00 USD
Sale Sold out
Shipping calculated at checkout.
UOM
Standard Range
Sensitivity

Contact us for 48 wells and bulk quote

Introducing the Human Bladder Cancer-Associated Nuclear Matrix Protein 4, BLCA-4 ELISA Kit, a cutting-edge diagnostic tool designed to accurately detect and quantify the presence of BLCA-4 in human bladder cancer samples. This high-quality ELISA kit is meticulously crafted using state-of-the-art technology and adheres to the strictest quality control measures, ensuring reliable and reproducible results.

The BLCA-4 ELISA Kit offers a comprehensive solution for researchers and clinicians seeking to investigate the role of BLCA-4 in bladder cancer progression and prognosis. With its user-friendly protocol and optimized reagents, this kit enables efficient and precise measurement of BLCA-4 levels, facilitating a deeper understanding of the disease and potentially aiding in the development of targeted therapies.

Featuring a robust and sensitive assay system, the BLCA-4 ELISA Kit exhibits exceptional specificity, minimizing the risk of false-positive or false-negative results. Its superior performance characteristics, including a wide dynamic range and low detection limit, guarantee accurate quantification of BLCA-4 levels even in samples with low concentrations.

The BLCA-4 ELISA Kit is designed to streamline laboratory workflows, offering a time-saving and cost-effective solution for bladder cancer research. Its ready-to-use components and straightforward procedure eliminate the need for complex sample preparation, allowing for rapid and efficient analysis.

With its unparalleled accuracy, reliability, and ease of use, the Human Bladder Cancer-Associated Nuclear Matrix Protein 4, BLCA-4 ELISA Kit is an indispensable tool for researchers and clinicians dedicated to advancing our understanding of bladder cancer and improving patient outcomes.

View full details